Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling-Reference-Cited by-同舟云学术

Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling

Published:2015-03 Issue:3 Volume:220 Page:331-340
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Wang Lingyan,Chen Buyuan,Lin Minhui,Cao Yanqin,Chen Yingyu,Chen Xinji,Liu Tingbo,Hu Jianda

Funder

National Natural Science Foundation of China

China-863 Program

National Public Health Grand Research Foundation

Fujian Provincial Key Scientific and Technological Projects

Educational Commission of Fujian Province, China

National Key Clinical Specialty Discipline Construction Program, China

Fujian Provicial Key Clinical Specialty Discipline Construction Program, China

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference31 articles.

1. LY294002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance;Barancík;Eur. J. Pharm. Sci.,2006

2. Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation;Cope;J. Cell Sci.,2014

3. Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer

4. The Akt kinases: isoform specificity in metabolism and cancer;Gonzalez;Cell Cycle,2009

5. Multidrug resistance in cancer: role of ATP–dependent transporters;Gottesman;Nat. Rev. Cancer,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia;Translational Oncology;2024-07

2. Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia;Frontiers in Oncology;2024-02-20

3. Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia;Cellular Oncology;2023-07-24

4. Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia;Frontiers in Pharmacology;2023-03-30

5. Loss of MiR-155 Sensitizes FLT3-ITD⁺AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1;Journal of Cancer;2023